A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.
Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.
Market Analysis and Insights: Global Infectious Vaccines Market
The global Infectious Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Infectious Vaccines Scope and Segment
The global Infectious Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Preventive Vaccine
Therapeutic Vaccine
By the end users/application, this report covers the following segments
Adults
Pediatrics
Competitive Landscape:
The report provides a list of all the key players in the Infectious Vaccines market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Infectious Vaccines key manufacturers in this market include:
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc. (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Sanofi Pasteur (France)
Pfizer Inc. (U.S.)
Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.
Market Analysis and Insights: Global Infectious Vaccines Market
The global Infectious Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Infectious Vaccines Scope and Segment
The global Infectious Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Preventive Vaccine
Therapeutic Vaccine
By the end users/application, this report covers the following segments
Adults
Pediatrics
Competitive Landscape:
The report provides a list of all the key players in the Infectious Vaccines market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Infectious Vaccines key manufacturers in this market include:
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc. (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Sanofi Pasteur (France)
Pfizer Inc. (U.S.)
1 Infectious Vaccines Market Overview
1.1 Infectious Vaccines Product Overview
1.2 Infectious Vaccines Market Segment by Type
1.2.1 Preventive Vaccine
1.2.2 Therapeutic Vaccine
1.3 Global Infectious Vaccines Market Size by Type
1.3.1 Global Infectious Vaccines Market Size Overview by Type (2016-2027)
1.3.2 Global Infectious Vaccines Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Infectious Vaccines Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Infectious Vaccines Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Infectious Vaccines Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Infectious Vaccines Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Infectious Vaccines Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Infectious Vaccines Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Infectious Vaccines Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Infectious Vaccines Sales Breakdown by Type (2016-2021)
1.4.2 Europe Infectious Vaccines Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Infectious Vaccines Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Infectious Vaccines Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Infectious Vaccines Sales Breakdown by Type (2016-2021)
2 Global Infectious Vaccines Market Competition by Company
2.1 Global Top Players by Infectious Vaccines Sales (2016-2021)
2.2 Global Top Players by Infectious Vaccines Revenue (2016-2021)
2.3 Global Top Players Infectious Vaccines Price (2016-2021)
2.4 Global Top Manufacturers Infectious Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Infectious Vaccines Market Competitive Situation and Trends
2.5.1 Infectious Vaccines Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Infectious Vaccines Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infectious Vaccines as of 2020)
2.7 Date of Key Manufacturers Enter into Infectious Vaccines Market
2.8 Key Manufacturers Infectious Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Infectious Vaccines Status and Outlook by Region
3.1 Global Infectious Vaccines Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Infectious Vaccines Historic Market Size by Region
3.2.1 Global Infectious Vaccines Sales in Volume by Region (2016-2021)
3.2.2 Global Infectious Vaccines Sales in Value by Region (2016-2021)
3.2.3 Global Infectious Vaccines Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Infectious Vaccines Forecasted Market Size by Region
3.3.1 Global Infectious Vaccines Sales in Volume by Region (2022-2027)
3.3.2 Global Infectious Vaccines Sales in Value by Region (2022-2027)
3.3.3 Global Infectious Vaccines Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Infectious Vaccines by Application
4.1 Infectious Vaccines Market Segment by Application
4.1.1 Adults
4.1.2 Pediatrics
4.2 Global Infectious Vaccines Market Size by Application
4.2.1 Global Infectious Vaccines Market Size Overview by Application (2016-2027)
4.2.2 Global Infectious Vaccines Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Infectious Vaccines Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Infectious Vaccines Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Infectious Vaccines Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Infectious Vaccines Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Infectious Vaccines Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Infectious Vaccines Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Infectious Vaccines Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Infectious Vaccines Sales Breakdown by Application (2016-2021)
4.3.2 Europe Infectious Vaccines Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Infectious Vaccines Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Infectious Vaccines Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Infectious Vaccines Sales Breakdown by Application (2016-2021)
5 North America Infectious Vaccines by Country
5.1 North America Infectious Vaccines Historic Market Size by Country
5.1.1 North America Infectious Vaccines Sales in Volume by Country (2016-2021)
5.1.2 North America Infectious Vaccines Sales in Value by Country (2016-2021)
5.2 North America Infectious Vaccines Forecasted Market Size by Country
5.2.1 North America Infectious Vaccines Sales in Volume by Country (2022-2027)
5.2.2 North America Infectious Vaccines Sales in Value by Country (2022-2027)
6 Europe Infectious Vaccines by Country
6.1 Europe Infectious Vaccines Historic Market Size by Country
6.1.1 Europe Infectious Vaccines Sales in Volume by Country (2016-2021)
6.1.2 Europe Infectious Vaccines Sales in Value by Country (2016-2021)
6.2 Europe Infectious Vaccines Forecasted Market Size by Country
6.2.1 Europe Infectious Vaccines Sales in Volume by Country (2022-2027)
6.2.2 Europe Infectious Vaccines Sales in Value by Country (2022-2027)
7 Asia-Pacific Infectious Vaccines by Region
7.1 Asia-Pacific Infectious Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Infectious Vaccines Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Infectious Vaccines Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Infectious Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Infectious Vaccines Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Infectious Vaccines Sales in Value by Region (2022-2027)
8 Latin America Infectious Vaccines by Country
8.1 Latin America Infectious Vaccines Historic Market Size by Country
8.1.1 Latin America Infectious Vaccines Sales in Volume by Country (2016-2021)
8.1.2 Latin America Infectious Vaccines Sales in Value by Country (2016-2021)
8.2 Latin America Infectious Vaccines Forecasted Market Size by Country
8.2.1 Latin America Infectious Vaccines Sales in Volume by Country (2022-2027)
8.2.2 Latin America Infectious Vaccines Sales in Value by Country (2022-2027)
9 Middle East and Africa Infectious Vaccines by Country
9.1 Middle East and Africa Infectious Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Infectious Vaccines Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Infectious Vaccines Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Infectious Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Infectious Vaccines Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Infectious Vaccines Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Infectious Vaccines Business
10.1 CSL Limited (Australia)
10.1.1 CSL Limited (Australia) Corporation Information
10.1.2 CSL Limited (Australia) Introduction and Business Overview
10.1.3 CSL Limited (Australia) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.1.4 CSL Limited (Australia) Infectious Vaccines Products Offered
10.1.5 CSL Limited (Australia) Recent Development
10.2 Bavarian Nordic (Denmark)
10.2.1 Bavarian Nordic (Denmark) Corporation Information
10.2.2 Bavarian Nordic (Denmark) Introduction and Business Overview
10.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.2.4 CSL Limited (Australia) Infectious Vaccines Products Offered
10.2.5 Bavarian Nordic (Denmark) Recent Development
10.3 GlaxoSmithKline plc. (U.K.)
10.3.1 GlaxoSmithKline plc. (U.K.) Corporation Information
10.3.2 GlaxoSmithKline plc. (U.K.) Introduction and Business Overview
10.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Products Offered
10.3.5 GlaxoSmithKline plc. (U.K.) Recent Development
10.4 Emergent Bio Solutions Inc. (U.S.)
10.4.1 Emergent Bio Solutions Inc. (U.S.) Corporation Information
10.4.2 Emergent Bio Solutions Inc. (U.S.) Introduction and Business Overview
10.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Products Offered
10.4.5 Emergent Bio Solutions Inc. (U.S.) Recent Development
10.5 MedImmune LLC (U.S.)
10.5.1 MedImmune LLC (U.S.) Corporation Information
10.5.2 MedImmune LLC (U.S.) Introduction and Business Overview
10.5.3 MedImmune LLC (U.S.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.5.4 MedImmune LLC (U.S.) Infectious Vaccines Products Offered
10.5.5 MedImmune LLC (U.S.) Recent Development
10.6 Johnson and Johnson (U.S.)
10.6.1 Johnson and Johnson (U.S.) Corporation Information
10.6.2 Johnson and Johnson (U.S.) Introduction and Business Overview
10.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Johnson and Johnson (U.S.) Infectious Vaccines Products Offered
10.6.5 Johnson and Johnson (U.S.) Recent Development
10.7 Novartis AG (Switzerland)
10.7.1 Novartis AG (Switzerland) Corporation Information
10.7.2 Novartis AG (Switzerland) Introduction and Business Overview
10.7.3 Novartis AG (Switzerland) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Novartis AG (Switzerland) Infectious Vaccines Products Offered
10.7.5 Novartis AG (Switzerland) Recent Development
10.8 Merck and Company (U.S.)
10.8.1 Merck and Company (U.S.) Corporation Information
10.8.2 Merck and Company (U.S.) Introduction and Business Overview
10.8.3 Merck and Company (U.S.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Merck and Company (U.S.) Infectious Vaccines Products Offered
10.8.5 Merck and Company (U.S.) Recent Development
10.9 Sanofi Pasteur (France)
10.9.1 Sanofi Pasteur (France) Corporation Information
10.9.2 Sanofi Pasteur (France) Introduction and Business Overview
10.9.3 Sanofi Pasteur (France) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Sanofi Pasteur (France) Infectious Vaccines Products Offered
10.9.5 Sanofi Pasteur (France) Recent Development
10.10 Pfizer Inc. (U.S.)
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Infectious Vaccines Product Category, Application and Specification
10.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Pfizer Inc. (U.S.) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Infectious Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Infectious Vaccines Industrial Chain Analysis
11.4 Infectious Vaccines Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Infectious Vaccines Distributors
12.3 Infectious Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Infectious Vaccines Product Overview
1.2 Infectious Vaccines Market Segment by Type
1.2.1 Preventive Vaccine
1.2.2 Therapeutic Vaccine
1.3 Global Infectious Vaccines Market Size by Type
1.3.1 Global Infectious Vaccines Market Size Overview by Type (2016-2027)
1.3.2 Global Infectious Vaccines Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Infectious Vaccines Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Infectious Vaccines Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Infectious Vaccines Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Infectious Vaccines Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Infectious Vaccines Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Infectious Vaccines Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Infectious Vaccines Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Infectious Vaccines Sales Breakdown by Type (2016-2021)
1.4.2 Europe Infectious Vaccines Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Infectious Vaccines Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Infectious Vaccines Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Infectious Vaccines Sales Breakdown by Type (2016-2021)
2 Global Infectious Vaccines Market Competition by Company
2.1 Global Top Players by Infectious Vaccines Sales (2016-2021)
2.2 Global Top Players by Infectious Vaccines Revenue (2016-2021)
2.3 Global Top Players Infectious Vaccines Price (2016-2021)
2.4 Global Top Manufacturers Infectious Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Infectious Vaccines Market Competitive Situation and Trends
2.5.1 Infectious Vaccines Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Infectious Vaccines Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infectious Vaccines as of 2020)
2.7 Date of Key Manufacturers Enter into Infectious Vaccines Market
2.8 Key Manufacturers Infectious Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Infectious Vaccines Status and Outlook by Region
3.1 Global Infectious Vaccines Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Infectious Vaccines Historic Market Size by Region
3.2.1 Global Infectious Vaccines Sales in Volume by Region (2016-2021)
3.2.2 Global Infectious Vaccines Sales in Value by Region (2016-2021)
3.2.3 Global Infectious Vaccines Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Infectious Vaccines Forecasted Market Size by Region
3.3.1 Global Infectious Vaccines Sales in Volume by Region (2022-2027)
3.3.2 Global Infectious Vaccines Sales in Value by Region (2022-2027)
3.3.3 Global Infectious Vaccines Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Infectious Vaccines by Application
4.1 Infectious Vaccines Market Segment by Application
4.1.1 Adults
4.1.2 Pediatrics
4.2 Global Infectious Vaccines Market Size by Application
4.2.1 Global Infectious Vaccines Market Size Overview by Application (2016-2027)
4.2.2 Global Infectious Vaccines Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Infectious Vaccines Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Infectious Vaccines Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Infectious Vaccines Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Infectious Vaccines Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Infectious Vaccines Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Infectious Vaccines Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Infectious Vaccines Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Infectious Vaccines Sales Breakdown by Application (2016-2021)
4.3.2 Europe Infectious Vaccines Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Infectious Vaccines Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Infectious Vaccines Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Infectious Vaccines Sales Breakdown by Application (2016-2021)
5 North America Infectious Vaccines by Country
5.1 North America Infectious Vaccines Historic Market Size by Country
5.1.1 North America Infectious Vaccines Sales in Volume by Country (2016-2021)
5.1.2 North America Infectious Vaccines Sales in Value by Country (2016-2021)
5.2 North America Infectious Vaccines Forecasted Market Size by Country
5.2.1 North America Infectious Vaccines Sales in Volume by Country (2022-2027)
5.2.2 North America Infectious Vaccines Sales in Value by Country (2022-2027)
6 Europe Infectious Vaccines by Country
6.1 Europe Infectious Vaccines Historic Market Size by Country
6.1.1 Europe Infectious Vaccines Sales in Volume by Country (2016-2021)
6.1.2 Europe Infectious Vaccines Sales in Value by Country (2016-2021)
6.2 Europe Infectious Vaccines Forecasted Market Size by Country
6.2.1 Europe Infectious Vaccines Sales in Volume by Country (2022-2027)
6.2.2 Europe Infectious Vaccines Sales in Value by Country (2022-2027)
7 Asia-Pacific Infectious Vaccines by Region
7.1 Asia-Pacific Infectious Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Infectious Vaccines Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Infectious Vaccines Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Infectious Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Infectious Vaccines Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Infectious Vaccines Sales in Value by Region (2022-2027)
8 Latin America Infectious Vaccines by Country
8.1 Latin America Infectious Vaccines Historic Market Size by Country
8.1.1 Latin America Infectious Vaccines Sales in Volume by Country (2016-2021)
8.1.2 Latin America Infectious Vaccines Sales in Value by Country (2016-2021)
8.2 Latin America Infectious Vaccines Forecasted Market Size by Country
8.2.1 Latin America Infectious Vaccines Sales in Volume by Country (2022-2027)
8.2.2 Latin America Infectious Vaccines Sales in Value by Country (2022-2027)
9 Middle East and Africa Infectious Vaccines by Country
9.1 Middle East and Africa Infectious Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Infectious Vaccines Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Infectious Vaccines Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Infectious Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Infectious Vaccines Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Infectious Vaccines Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Infectious Vaccines Business
10.1 CSL Limited (Australia)
10.1.1 CSL Limited (Australia) Corporation Information
10.1.2 CSL Limited (Australia) Introduction and Business Overview
10.1.3 CSL Limited (Australia) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.1.4 CSL Limited (Australia) Infectious Vaccines Products Offered
10.1.5 CSL Limited (Australia) Recent Development
10.2 Bavarian Nordic (Denmark)
10.2.1 Bavarian Nordic (Denmark) Corporation Information
10.2.2 Bavarian Nordic (Denmark) Introduction and Business Overview
10.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.2.4 CSL Limited (Australia) Infectious Vaccines Products Offered
10.2.5 Bavarian Nordic (Denmark) Recent Development
10.3 GlaxoSmithKline plc. (U.K.)
10.3.1 GlaxoSmithKline plc. (U.K.) Corporation Information
10.3.2 GlaxoSmithKline plc. (U.K.) Introduction and Business Overview
10.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Products Offered
10.3.5 GlaxoSmithKline plc. (U.K.) Recent Development
10.4 Emergent Bio Solutions Inc. (U.S.)
10.4.1 Emergent Bio Solutions Inc. (U.S.) Corporation Information
10.4.2 Emergent Bio Solutions Inc. (U.S.) Introduction and Business Overview
10.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Products Offered
10.4.5 Emergent Bio Solutions Inc. (U.S.) Recent Development
10.5 MedImmune LLC (U.S.)
10.5.1 MedImmune LLC (U.S.) Corporation Information
10.5.2 MedImmune LLC (U.S.) Introduction and Business Overview
10.5.3 MedImmune LLC (U.S.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.5.4 MedImmune LLC (U.S.) Infectious Vaccines Products Offered
10.5.5 MedImmune LLC (U.S.) Recent Development
10.6 Johnson and Johnson (U.S.)
10.6.1 Johnson and Johnson (U.S.) Corporation Information
10.6.2 Johnson and Johnson (U.S.) Introduction and Business Overview
10.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Johnson and Johnson (U.S.) Infectious Vaccines Products Offered
10.6.5 Johnson and Johnson (U.S.) Recent Development
10.7 Novartis AG (Switzerland)
10.7.1 Novartis AG (Switzerland) Corporation Information
10.7.2 Novartis AG (Switzerland) Introduction and Business Overview
10.7.3 Novartis AG (Switzerland) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Novartis AG (Switzerland) Infectious Vaccines Products Offered
10.7.5 Novartis AG (Switzerland) Recent Development
10.8 Merck and Company (U.S.)
10.8.1 Merck and Company (U.S.) Corporation Information
10.8.2 Merck and Company (U.S.) Introduction and Business Overview
10.8.3 Merck and Company (U.S.) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Merck and Company (U.S.) Infectious Vaccines Products Offered
10.8.5 Merck and Company (U.S.) Recent Development
10.9 Sanofi Pasteur (France)
10.9.1 Sanofi Pasteur (France) Corporation Information
10.9.2 Sanofi Pasteur (France) Introduction and Business Overview
10.9.3 Sanofi Pasteur (France) Infectious Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Sanofi Pasteur (France) Infectious Vaccines Products Offered
10.9.5 Sanofi Pasteur (France) Recent Development
10.10 Pfizer Inc. (U.S.)
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Infectious Vaccines Product Category, Application and Specification
10.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Pfizer Inc. (U.S.) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Infectious Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Infectious Vaccines Industrial Chain Analysis
11.4 Infectious Vaccines Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Infectious Vaccines Distributors
12.3 Infectious Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
